Nuveen Asset Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$1.59M Sell
182,668
-74,212
-29% -$646K ﹤0.01% 2483
2024
Q3
$5.02M Sell
256,880
-5,171
-2% -$101K ﹤0.01% 1984
2024
Q2
$5.4M Buy
262,051
+51,885
+25% +$1.07M ﹤0.01% 1910
2024
Q1
$4.48M Buy
210,166
+10,753
+5% +$229K ﹤0.01% 2043
2023
Q4
$2.87M Sell
199,413
-531,130
-73% -$7.64M ﹤0.01% 2241
2023
Q3
$6.66M Buy
730,543
+70,585
+11% +$644K ﹤0.01% 1716
2023
Q2
$6.98M Sell
659,958
-143
-0% -$1.51K ﹤0.01% 1722
2023
Q1
$8.07M Sell
660,101
-35,560
-5% -$435K ﹤0.01% 1620
2022
Q4
$8.63M Buy
695,661
+355,277
+104% +$4.41M ﹤0.01% 1590
2022
Q3
$4.65M Buy
340,384
+114,042
+50% +$1.56M ﹤0.01% 1949
2022
Q2
$4.15M Sell
226,342
-298,844
-57% -$5.48M ﹤0.01% 2066
2022
Q1
$8.35M Buy
525,186
+75,340
+17% +$1.2M ﹤0.01% 1765
2021
Q4
$6.3M Sell
449,846
-19,746
-4% -$276K ﹤0.01% 1978
2021
Q3
$8.8M Buy
469,592
+95,684
+26% +$1.79M ﹤0.01% 1869
2021
Q2
$7.8M Buy
373,908
+83,989
+29% +$1.75M ﹤0.01% 2009
2021
Q1
$8.2M Sell
289,919
-441,950
-60% -$12.5M ﹤0.01% 1905
2020
Q4
$23.9M Sell
731,869
-105,583
-13% -$3.45M 0.01% 1137
2020
Q3
$25.7M Buy
837,452
+49,476
+6% +$1.52M 0.01% 917
2020
Q2
$12.8M Buy
787,976
+400,579
+103% +$6.53M 0.01% 1314
2020
Q1
$3.85M Buy
387,397
+79,639
+26% +$792K ﹤0.01% 1859
2019
Q4
$4.23M Sell
307,758
-75,802
-20% -$1.04M ﹤0.01% 2076
2019
Q3
$5.82M Buy
383,560
+286,685
+296% +$4.35M ﹤0.01% 1880
2019
Q2
$1.91M Buy
+96,875
New +$1.91M ﹤0.01% 2456